Anastrozole has no harsh side effects. Actually, affecting estradiol, it can suppress the level of the good cholesterol (HDL). However, when compared to AI like letrozole, anastrozole is preferable. Letrozole has quite a few side effects, the most common of which is erectile dysfunction. Although estradiol is known as a female hormone, men still need it. Estradiol maintains hormonal balance, participates in a great number of physiological processes and helps to gain muscle mass and strength. Such potent AI as letrozole kills almost all estradiol, disrupting the hormonal balance and causing a number of side effects, such as erectile dysfunction, joint pain, bones fragility, unwellness, etc. Anastrozole acts more smoothly and does not kill all estradiol immediately, allowing you to more finely adjust the hormonal balance.
Can someone help me out? How long can someone estrogen remain “out of balance”? Did a test cycle one year ago, 500mg test e a year a go, started ai in week 4, dropped Ai for pct. nolva/clomid pct 40/100 for two weeks and 20/50 for two weeks. I was told to pin my hcg on two shots during pct. what would this do to my estrogen levels? My symptoms are Mostly Mild but include soft erections,cystic acne, anxiety, creaky joints, slight libido change and at times I’m emotional. I thought that my it could be high estero so I took .25 mg of arimidex eod for two weeks, felt a tad bit of relief but I’m convinced it was placebo because they feeling of normalness went away after a few days. Went to the doctor and everything is with in normal range. They won’t test my estro though. The reason why I’m asking is because I want to do another cycle and just restart again. I have not felt normal in a while, but just very subtly. HELP
Although deaths from methadone are on the rise, methadone-associated deaths are not being caused primarily by methadone intended for methadone treatment programs, according to a panel of experts convened by the Substance Abuse and Mental Health Services Administration , which released a report titled "Methadone-Associated Mortality, Report of a National Assessment". The consensus report concludes that "although the data remains incomplete, National Assessment meeting participants concurred that methadone tablets or diskettes distributed through channels other than opioid treatment programs most likely are the central factors in methadone-associated mortality."